235 related articles for article (PubMed ID: 26556483)
1. Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis.
Liu F; Wang X; Wu G; Chen L; Hu P; Ren H; Hu H
PLoS One; 2015; 10(11):e0142457. PubMed ID: 26556483
[TBL] [Abstract][Full Text] [Related]
2. Impact of caffeine in hepatitis C virus infection: a systematic review and meta-analysis.
Wijarnpreecha K; Thongprayoon C; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):17-22. PubMed ID: 27676091
[TBL] [Abstract][Full Text] [Related]
3. Increased caffeine consumption is associated with reduced hepatic fibrosis.
Modi AA; Feld JJ; Park Y; Kleiner DE; Everhart JE; Liang TJ; Hoofnagle JH
Hepatology; 2010 Jan; 51(1):201-9. PubMed ID: 20034049
[TBL] [Abstract][Full Text] [Related]
4. Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C.
Khalaf N; White D; Kanwal F; Ramsey D; Mittal S; Tavakoli-Tabasi S; Kuzniarek J; El-Serag HB
Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1521-31.e3. PubMed ID: 25777972
[TBL] [Abstract][Full Text] [Related]
5. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G
Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021
[TBL] [Abstract][Full Text] [Related]
6. Systematic review with meta-analysis: coffee consumption and the risk of cirrhosis.
Kennedy OJ; Roderick P; Buchanan R; Fallowfield JA; Hayes PC; Parkes J
Aliment Pharmacol Ther; 2016 Mar; 43(5):562-74. PubMed ID: 26806124
[TBL] [Abstract][Full Text] [Related]
7. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Wijarnpreecha K; Thongprayoon C; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):e8-e12. PubMed ID: 27824642
[TBL] [Abstract][Full Text] [Related]
8. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.
Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416
[TBL] [Abstract][Full Text] [Related]
9. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies.
Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919
[TBL] [Abstract][Full Text] [Related]
10. The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies.
Hayat U; Siddiqui AA; Okut H; Afroz S; Tasleem S; Haris A
Ann Hepatol; 2021; 20():100254. PubMed ID: 32920163
[TBL] [Abstract][Full Text] [Related]
11. Coffee, cirrhosis, and transaminase enzymes.
Klatsky AL; Morton C; Udaltsova N; Friedman GD
Arch Intern Med; 2006 Jun; 166(11):1190-5. PubMed ID: 16772246
[TBL] [Abstract][Full Text] [Related]
12. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis.
Kamal S; Khan MA; Seth A; Cholankeril G; Gupta D; Singh U; Kamal F; Howden CW; Stave C; Nair S; Satapathy SK; Ahmed A
Am J Gastroenterol; 2017 Oct; 112(10):1495-1505. PubMed ID: 28585556
[TBL] [Abstract][Full Text] [Related]
13. Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.
Jaruvongvanich V; Sanguankeo A; Klomjit N; Upala S
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):46-55. PubMed ID: 27350575
[TBL] [Abstract][Full Text] [Related]
14. An epidemiological study of the association of coffee with chronic liver disease.
Walton HB; Masterton GS; Hayes PC
Scott Med J; 2013 Nov; 58(4):217-22. PubMed ID: 24215040
[TBL] [Abstract][Full Text] [Related]
15. Coffee consumption and the risk of gastric cancer: a meta-analysis of prospective cohort studies.
Li L; Gan Y; Wu C; Qu X; Sun G; Lu Z
BMC Cancer; 2015 Oct; 15():733. PubMed ID: 26481317
[TBL] [Abstract][Full Text] [Related]
16. Association of coffee consumption and chronic kidney disease: A meta-analysis.
Wijarnpreecha K; Thongprayoon C; Thamcharoen N; Panjawatanan P; Cheungpasitporn W
Int J Clin Pract; 2017 Jan; 71(1):. PubMed ID: 27933694
[TBL] [Abstract][Full Text] [Related]
17. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis.
Kositamongkol C; Kanchanasurakit S; Auttamalang C; Inchai N; Kabkaew T; Kitpark S; Chaiyakunapruk N; Duangjai A; Saokaew S; Phisalprapa P
Front Pharmacol; 2021; 12():786596. PubMed ID: 34966282
[No Abstract] [Full Text] [Related]
18. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies.
Larsson SC; Orsini N
Am J Epidemiol; 2011 Nov; 174(9):993-1001. PubMed ID: 21920945
[TBL] [Abstract][Full Text] [Related]
19. Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.
Iqbal U; Dennis BB; Li AA; Cholankeril G; Kim D; Khan MA; Ahmed A
Hepatol Int; 2019 Jan; 13(1):84-90. PubMed ID: 30539518
[TBL] [Abstract][Full Text] [Related]
20. Interaction of alcohol intake and cofactors on the risk of cirrhosis.
Stroffolini T; Cotticelli G; Medda E; Niosi M; Del Vecchio-Blanco C; Addolorato G; Petrelli E; Salerno MT; Picardi A; Bernardi M; Almasio P; Bellentani S; Surace LA; Loguercio C
Liver Int; 2010 Jul; 30(6):867-70. PubMed ID: 20492499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
